WCLC 2022 Conference Coverage


 

Lecture Summary - WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Malignant Pleural Mesothelioma

9 views
September 7, 2022
Comments 0
Login to view comments. Click here to Login